Diagnostic Fine-Needle Biopsy of Small Solid Pancreatic Lesions Using a Franseen Needle during Endoscopic Ultrasound Examination.

EUS-FNB Franseen needle histopathological assessment small pancreatic lesions

Journal

Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402

Informations de publication

Date de publication:
25 Dec 2020
Historique:
received: 13 11 2020
revised: 07 12 2020
accepted: 23 12 2020
entrez: 30 12 2020
pubmed: 31 12 2020
medline: 31 12 2020
Statut: epublish

Résumé

During endoscopic ultrasound-guided fine needle aspiration biopsy (EUS-FNB), Franseen needles can help collect sufficient tissue to permit histopathological assessment. However, its efficacy might be limited by the size of the targeted lesion. This study aimed to evaluate the feasibility of histopathological assessment of small solid pancreatic lesions using a 22-gauge Franseen needle during EUS-FNB. This retrospective study evaluated data from all patients who underwent EUS-FNB using a Franseen needle for solid pancreatic lesions at the University of Toyama Hospital between June 2018 and April 2020. The study included 159 patients who had 152 malignant lesions and 7 benign lesions. The malignant lesions included pancreatic cancers ( The diagnostic accuracy for small lesions (<10 mm), especially for lesions of <5 mm, based on histological examination alone, was significantly lower than that for others (>10 mm). Furthermore, multivariate analysis revealed that only lesion size was an independent predictor of histopathological diagnosis accuracy.

Sections du résumé

BACKGROUND AND AIM OBJECTIVE
During endoscopic ultrasound-guided fine needle aspiration biopsy (EUS-FNB), Franseen needles can help collect sufficient tissue to permit histopathological assessment. However, its efficacy might be limited by the size of the targeted lesion. This study aimed to evaluate the feasibility of histopathological assessment of small solid pancreatic lesions using a 22-gauge Franseen needle during EUS-FNB.
METHODS METHODS
This retrospective study evaluated data from all patients who underwent EUS-FNB using a Franseen needle for solid pancreatic lesions at the University of Toyama Hospital between June 2018 and April 2020.
RESULTS RESULTS
The study included 159 patients who had 152 malignant lesions and 7 benign lesions. The malignant lesions included pancreatic cancers (
CONCLUSIONS CONCLUSIONS
The diagnostic accuracy for small lesions (<10 mm), especially for lesions of <5 mm, based on histological examination alone, was significantly lower than that for others (>10 mm). Furthermore, multivariate analysis revealed that only lesion size was an independent predictor of histopathological diagnosis accuracy.

Identifiants

pubmed: 33375661
pii: diagnostics11010027
doi: 10.3390/diagnostics11010027
pmc: PMC7823918
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

J Gastroenterol Hepatol. 2019 May;34(5):907-913
pubmed: 30422342
Gut. 2018 Dec;67(12):2081-2084
pubmed: 28988195
Am J Gastroenterol. 2004 May;99(5):844-50
pubmed: 15128348
J Hepatobiliary Pancreat Sci. 2014 May;21(5):E29-33
pubmed: 24353093
Am J Gastroenterol. 2012 Mar;107(3):397-404
pubmed: 21989147
Dig Endosc. 2020 Mar;32(3):399-408
pubmed: 31361926
Gastrointest Endosc. 2015 Jan;81(1):177-85
pubmed: 25440688
Gastrointest Endosc. 2010 Jul;72(1):78-83, 83.e1-2
pubmed: 20620274
Dig Endosc. 2019 Mar;31(2):197-202
pubmed: 30256458
Lancet. 2016 Jul 2;388(10039):73-85
pubmed: 26830752
Endosc Ultrasound. 2019 Jan-Feb;8(1):50-57
pubmed: 29786033
Endosc Int Open. 2017 May;5(5):E363-E375
pubmed: 28497108
J Gastroenterol. 2013 Aug;48(8):973-81
pubmed: 23090002
Gastroenterol Clin North Am. 2012 Mar;41(1):179-88
pubmed: 22341257
Dig Dis Sci. 2020 Apr;65(4):1155-1163
pubmed: 31531819
Endosc Ultrasound. 2020 Jul-Aug;9(4):225-231
pubmed: 32655082
Endosc Ultrasound. 2019 Mar-Apr;8(2):99-104
pubmed: 29623911
Gastrointest Endosc. 2010 Mar;71(3):446-54
pubmed: 20189503
J Gastroenterol Hepatol. 2011 Aug;26(8):1256-61
pubmed: 21501226
Clin Gastroenterol Hepatol. 2012 Mar;10(3):316-22
pubmed: 22019795
Dig Endosc. 2017 May;29(3):338-346
pubmed: 27878861
Endosc Int Open. 2019 Nov;7(11):E1327-E1332
pubmed: 31673602
Dig Endosc. 2020 Jan;32(1):114-126
pubmed: 31166046

Auteurs

Kosuke Takahashi (K)

Third Department of Internal Medicine, University of Toyama, Toyama, 2630 Sugitani, Toyama 930-0194, Japan.

Ichiro Yasuda (I)

Third Department of Internal Medicine, University of Toyama, Toyama, 2630 Sugitani, Toyama 930-0194, Japan.

Tatsuyuki Hanaoka (T)

Third Department of Internal Medicine, University of Toyama, Toyama, 2630 Sugitani, Toyama 930-0194, Japan.

Yuka Hayashi (Y)

Third Department of Internal Medicine, University of Toyama, Toyama, 2630 Sugitani, Toyama 930-0194, Japan.

Yasuhiro Araki (Y)

Third Department of Internal Medicine, University of Toyama, Toyama, 2630 Sugitani, Toyama 930-0194, Japan.

Iori Motoo (I)

Third Department of Internal Medicine, University of Toyama, Toyama, 2630 Sugitani, Toyama 930-0194, Japan.

Shinya Kajiura (S)

Third Department of Internal Medicine, University of Toyama, Toyama, 2630 Sugitani, Toyama 930-0194, Japan.

Takayuki Ando (T)

Third Department of Internal Medicine, University of Toyama, Toyama, 2630 Sugitani, Toyama 930-0194, Japan.

Haruka Fujinami (H)

Third Department of Internal Medicine, University of Toyama, Toyama, 2630 Sugitani, Toyama 930-0194, Japan.

Kazuto Tajiri (K)

Third Department of Internal Medicine, University of Toyama, Toyama, 2630 Sugitani, Toyama 930-0194, Japan.

Masami Minemura (M)

Third Department of Internal Medicine, University of Toyama, Toyama, 2630 Sugitani, Toyama 930-0194, Japan.

Terumi Takahara (T)

Third Department of Internal Medicine, University of Toyama, Toyama, 2630 Sugitani, Toyama 930-0194, Japan.

Classifications MeSH